Early Efficacy of Ferric Carboxymaltose (Ferinject®) in Patients with Iron-Deficiency Anemia: Single Institution Experience

被引：0
|
作者：
Kerbage, Fouad [1 ,2 ,3 ]
Sakr, Riwa [2 ,3 ]
Akoury, Elie [2 ,3 ]
Eid, Anthony [2 ,3 ]
Chahine, Georges [2 ,3 ]
Massoud, Marcel [2 ,3 ]
机构：
[1] Inst Gustave Roussy, Hematol Dept, Villejuif, France
[2] Holy Spirit Univ Kaslik, Jounieh, Lebanon
[3] UHC Notre Dame Secours, Jbeil, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Ferric Carboxymaltose; Early Efficacy; Iron Deficiency Anemia;
D O I：
10.1016/j.clml.2018.07.245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RES-056
引用
下载
收藏
页码：S296 / S297
页数：2
相关论文
共 50 条
  • [1] HEALTH ECONOMIC EVALUATION OF FERRIC CARBOXYMALTOSE (FERINJECT®) IN PATIENTS WITH IRON DEFICIENCY ANEMIA
    Zakin, L.
    Asbun-Bojalil, J.
    Chiu-Ugalde, J.
    Wernli, J.
    Cirrincione, A.
    VALUE IN HEALTH, 2014, 17 (03) : A229 - A229
  • [2] Ferric carboxymaltose for the treatment of iron-deficiency anemia
    Munoz, Manuel
    Martin-Montanez, Elisa
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (06) : 907 - 921
  • [3] Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
    Aktas, Burak Yasin
    Ata, Emine Busra
    Cesmeci, Engin
    Cakir, Ibrahim Yahya
    Coskunpinar, Muharrem
    Tahillioglu, Yagmur
    Guner, Gurkan
    Guven, Deniz Can
    Arik, Zafer
    Kertmen, Neyran
    Dizdar, Omer
    Yalcin, Suayib
    Aksoy, Sercan
    CURRENT ONCOLOGY, 2023, 30 (11) : 9689 - 9700
  • [4] Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
    Eun-A Lim
    Hyun-Soon Sohn
    Haeyoung Lee
    Sang-Eun Choi
    Cost Effectiveness and Resource Allocation, 12
  • [5] Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
    Lim, Eun-A
    Sohn, Hyun-Soon
    Lee, Haeyoung
    Choi, Sang-Eun
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2014, 12
  • [6] Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Bregman, David B.
    Goodnough, Lawrence T.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (02) : 48 - 60
  • [7] Efficacy of ferric carboxymaltose in iron deficiency anemia patients scheduled for pancreaticoduodenectomy
    Park, Jangho
    Park, Sang-Jae
    Han, Sung-Sik
    Park, Hyeong Min
    Yu, Jihye
    Park, Boram
    Kim, Young -Woo
    Kim, Sun-Whe
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2023, 105 (02) : 82 - 90
  • [8] Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia
    Ding, Yanhua
    Zhu, Xiaoxue
    Li, Xiaojiao
    Zhang, Hong
    Wu, Min
    Liu, Jingrui
    Palmen, Mary
    Roubert, Bernard
    Li, Cuiyun
    CLINICAL THERAPEUTICS, 2020, 42 (02) : 276 - 285
  • [9] Treatment of tumor induced iron deficiency with ferric carboxymaltose (FCM, ferinject®)
    Steinmetz, T.
    Tschechne, B.
    Selak, E.
    Kellner, T.
    Schroeder, D.
    Marschner, N.
    Virgin, G.
    Kaldeweier, A.
    ONKOLOGIE, 2010, 33 : 74 - 74
  • [10] Ferric Carboxymaltose (Injectafer) for Iron Deficiency Anemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1431): : 99 - 100
12345